Consensus Recommendations for MRD Testing in Adult B-Cell Acute Lymphoblastic Leukemia in Ontario

Measurable (minimal) residual disease (MRD) is an established, key prognostic factor in adult B-cell acute lymphoblastic leukemia (B-ALL), and testing for MRD is known to be an important tool to help guide treatment decisions. The clinical value of MRD testing depends on the accuracy and reliability...

Descripción completa

Detalles Bibliográficos
Autores principales: Tierens, Anne, Stockley, Tracy L., Campbell, Clinton, Fulcher, Jill, Leber, Brian, McCready, Elizabeth, Sabatini, Peter J. B., Sadikovic, Bekim, Schuh, Andre C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025812/
https://www.ncbi.nlm.nih.gov/pubmed/33808300
http://dx.doi.org/10.3390/curroncol28020131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025812/
https://www.ncbi.nlm.nih.gov/pubmed/33808300
http://dx.doi.org/10.3390/curroncol28020131

Ejemplares similares